SY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SY is not a good buy right now. The stock is trading below the key pivot (2.938) with only weak/indecisive momentum signals, while fundamentals show deteriorating profitability (large YoY net income and EPS decline) and margin compression. With no Intellectia buy signals and no near-term positive news catalysts, the risk/reward does not favor an immediate entry for an impatient buyer; the better decision is to avoid/exit until price reclaims resistance (~2.94–3.20) and fundamentals stabilize.
Trend/momentum is mixed-to-bearish near-term. Post-market price ~2.85 sits below the pivot at 2.938, indicating the stock is currently trading in a weaker zone. MACD histogram is positive (0.0297) but contracting, suggesting upside momentum is fading rather than accelerating. RSI(6) at ~45.4 is neutral, not signaling an oversold bounce. Moving averages are converging, consistent with consolidation after weakness rather than a confirmed uptrend. Levels: Support S1=2.674 then S2=2.511; Resistance R1=3.201 then R2=3.364. A cleaner buy setup would typically require reclaiming 2.94 and holding above it with improving momentum.
Upcoming earnings (2026-02-16 pre-market) could act as an event-driven catalyst if results or guidance improve.
Options skew is modestly call-favoring (PCRs < 1), hinting at some market participants positioning for upside.
Pattern-based forecast shows a small positive bias over 1 month (+0.6%), though edge is weak.
Profitability deterioration: 2025/Q3 net income and EPS collapsed YoY, increasing the chance of continued negative sentiment until evidence of a turnaround emerges.
Margin pressure: gross margin down materially YoY, which can weigh on valuation and confidence.
Price is below pivot resistance (2.
and momentum is not improving (MACD contracting), increasing the odds of a drift toward support (2.674/2.511).
No positive news flow in the past week to shift sentiment.
Latest quarter: 2025/Q3. Revenue grew to 386.67M (+3.99% YoY), but profitability worsened sharply: Net income fell to -64.28M (-415.88% YoY) and EPS to -0.83 (-419.23% YoY). Gross margin declined to 47.29% (-23.43% YoY). Summary: modest top-line growth but significant bottom-line and margin deterioration—currently a negative growth-quality mix.
No analyst rating or price target change data was provided, so there is no observable recent Wall Street upgrade/downgrade trend to lean on. Practical read: without supportive analyst/target momentum in the dataset, the decision must rely on price action + fundamentals, both of which are not confirming a buy now. Influential trading: hedge funds and insiders are neutral; no recent Congress trading data is available.
